These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7811936)

  • 1. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths.
    Snyder SW; Ladror US; Wade WS; Wang GT; Barrett LW; Matayoshi ED; Huffaker HJ; Krafft GA; Holzman TF
    Biophys J; 1994 Sep; 67(3):1216-28. PubMed ID: 7811936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solvent effects on self-assembly of beta-amyloid peptide.
    Shen CL; Murphy RM
    Biophys J; 1995 Aug; 69(2):640-51. PubMed ID: 8527678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: Abeta association kinetics at endosomal pH.
    Gorman PM; Yip CM; Fraser PE; Chakrabartty A
    J Mol Biol; 2003 Jan; 325(4):743-57. PubMed ID: 12507477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.
    Shen CL; Fitzgerald MC; Murphy RM
    Biophys J; 1994 Sep; 67(3):1238-46. PubMed ID: 7811938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
    Burdick D; Soreghan B; Kwon M; Kosmoski J; Knauer M; Henschen A; Yates J; Cotman C; Glabe C
    J Biol Chem; 1992 Jan; 267(1):546-54. PubMed ID: 1730616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta.
    Wood SJ; Maleeff B; Hart T; Wetzel R
    J Mol Biol; 1996 Mar; 256(5):870-7. PubMed ID: 8601838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils.
    LeVine H
    Arch Biochem Biophys; 1997 Jun; 342(2):306-16. PubMed ID: 9186492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racemization: its biological significance on neuropathogenesis of Alzheimer's disease.
    Mori H; Ishii K; Tomiyama T; Furiya Y; Sahara N; Asano S; Endo N; Shirasawa T; Takio K
    Tohoku J Exp Med; 1994 Nov; 174(3):251-62. PubMed ID: 7761990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
    Abelein A; Gräslund A; Danielsson J
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy.
    Nichols MR; Moss MA; Reed DK; Lin WL; Mukhopadhyay R; Hoh JH; Rosenberry TL
    Biochemistry; 2002 May; 41(19):6115-27. PubMed ID: 11994007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide.
    Shen CL; Scott GL; Merchant F; Murphy RM
    Biophys J; 1993 Dec; 65(6):2383-95. PubMed ID: 8312477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-dependent structural transitions of Alzheimer amyloid peptides.
    Fraser PE; Nguyen JT; Surewicz WK; Kirschner DA
    Biophys J; 1991 Nov; 60(5):1190-201. PubMed ID: 1760507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical models of the ion channel structure of amyloid beta-protein.
    Durell SR; Guy HR; Arispe N; Rojas E; Pollard HB
    Biophys J; 1994 Dec; 67(6):2137-45. PubMed ID: 7535109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
    Kim W; Hecht MH
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding of DNA to aggregated forms of Alzheimer's disease amyloid peptides.
    Camero S; Ayuso JM; Barrantes A; Benítez MJ; Jiménez JS
    Int J Biol Macromol; 2013 Apr; 55():201-6. PubMed ID: 23352599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules.
    Wärmländer S; Tiiman A; Abelein A; Luo J; Jarvet J; Söderberg KL; Danielsson J; Gräslund A
    Chembiochem; 2013 Sep; 14(14):1692-704. PubMed ID: 23983094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.